Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Gastroenterology. 2010 Jun;138(7):2348-56. doi: 10.1053/j.gastro.2010.02.016. Epub 2010 Feb 20.
BACKGROUND & AIMS: The influence of osteoporosis and liver disease on fracture risk is not well characterized in patients with primary biliary cirrhosis (PBC). We studied a large series of women with PBC to assess the prevalence and risk factors for fractures and the fracture threshold.
In female patients with PBC (n = 185; age, 55.7 +/- 0.7 years; range 28-79 years), age, duration of PBC, menopausal status, and histologic stage and severity of liver disease were assessed. Vertebral and non-vertebral fractures were recorded in 170 and 172 patients, respectively. Osteoporosis and osteopenia were diagnosed based on densitometry analysis.
The prevalences of vertebral, non-vertebral, and overall fractures were 11.2%, 12.2%, 20.8%, respectively. Osteoporosis was significantly more frequent in patients with PBC than in normal women. Osteoporosis was associated with age, weight, height, histologic stage, severity, and duration of liver damage; fractures were associated with osteoporosis, menopause, age, and height but not with severity of PBC. Osteoporosis was a risk factor for vertebral fracture (odds ratio [OR], 8.48; 95% confidence interval [CI]: 2.67-26.95). Lumbar T score <-1.5 (OR, 8.27; 95% CI: 1.84-37.08) and femoral neck T score <-1.5 (OR, 6.83; 95% CI: 1.48-31.63) were significant risk factors for vertebral fractures.
Fractures, particularly vertebral fractures, are associated with osteoporosis, osteopenia, and T scores less than -1.5, whereas osteoporosis and osteopenia are associated with the severity of liver damage. Patients with T scores less than -1.5 might require additional monitoring and be considered for therapy to prevent fractures.
骨质疏松症和肝脏疾病对原发性胆汁性肝硬化(PBC)患者骨折风险的影响尚不清楚。我们研究了一系列患有 PBC 的女性患者,以评估骨折的患病率和危险因素,以及骨折阈值。
在 185 例患有 PBC 的女性患者(年龄 55.7 +/- 0.7 岁;范围 28-79 岁)中,评估了年龄、PBC 持续时间、绝经状态以及肝脏疾病的组织学分期和严重程度。分别在 170 例和 172 例患者中记录了椎体和非椎体骨折。基于骨密度分析诊断骨质疏松症和骨量减少症。
椎体、非椎体和总体骨折的患病率分别为 11.2%、12.2%和 20.8%。患有 PBC 的患者骨质疏松症的发生率明显高于正常女性。骨质疏松症与年龄、体重、身高、组织学分期、严重程度和肝损伤持续时间有关;骨折与骨质疏松症、绝经、年龄和身高有关,但与 PBC 的严重程度无关。骨质疏松症是椎体骨折的危险因素(比值比[OR],8.48;95%置信区间[CI]:2.67-26.95)。腰椎 T 评分<-1.5(OR,8.27;95% CI:1.84-37.08)和股骨颈 T 评分<-1.5(OR,6.83;95% CI:1.48-31.63)是椎体骨折的显著危险因素。
骨折,特别是椎体骨折,与骨质疏松症、骨量减少症和 T 评分低于-1.5 有关,而骨质疏松症和骨量减少症与肝损伤的严重程度有关。T 评分低于-1.5 的患者可能需要额外的监测,并考虑进行治疗以预防骨折。